Kaplan R S, Pedersen P L
Biochem J. 1983 May 15;212(2):279-88. doi: 10.1042/bj2120279.
ATP hydrolysis catalysed by the H+-ATPase of intact mitochondria can be induced by addition of ATP in the presence of valinomycin and KCl. This leads to an increase in intramitochondrial Pi and therefore allows investigation of potential Pi efflux pathways in intact mitochondria. Combining this approach with the direct measurement of both internal and external Pi, we have attempted to determine whether Pi efflux occurs via an atractyloside-sensitive transporter, by the classical operation of the Pi/H+ and Pi/dicarboxylate carriers, and/or by other mechanisms. Initial experiments re-examined the evidence that led to the current view that one efflux pathway for Pi is an atractyloside-sensitive ATP/ADP,0.5Pi transporter. No evidence was found in support of this efflux pathway. Rather, atractyloside-sensitivity of the low rate of Pi efflux observed in previous studies (oligomycin present) was accounted for by ATP entry on the well known ATP/ADP transport system followed by hydrolysis of ATP and subsequent Pi efflux. Thus, under these conditions, where ATP hydrolysis is not completely inhibited, Pi efflux becomes atractyloside sensitive most likely because this inhibitor blocks ATP entry, not because it directly inhibits Pi efflux. Substantial efflux of Pi from rat liver mitochondria is observed on generation of high levels of matrix Pi by ATP hydrolysis induced by valinomycin and K+ (oligomycin absent). A portion of this efflux can be inhibited by thiol-specific reagents at concentrations that normally inhibit the Pi/H+ and Pi/dicarboxylate carriers. However, a significant fraction of efflux continues even in the presence of p-chloromercuribenzoate, N-ethylmaleimide plus n-butylmalonate or mersalyl. The mersalyl-insensitive Pi efflux, which is also insensitive to carboxyatractyloside, is a saturable process, thus suggesting carrier mediation. During this efflux the mitochondrial inner membrane retains considerable impermeability to other low-molecular-weight anions (i.e., malate, 2-oxoglutarate). In conclusion, results presented here rule out an atractyloside-sensitive ATP/ADP,0.5Pi transport system as a mechanism for Pi efflux in rat liver mitochondria. Rather Pi efflux appears to occur on the classical Pi/H+ transport system as well as via a mersalyl-insensitive saturable process. The inhibitor-insensitive Pi efflux may occur on a portion of the Pi/H+ carrier molecules that exist in a state different from that normally catalysing Pi influx. Alternatively, a separate Pi efflux carrier may exist.
完整线粒体的H⁺ -ATP酶催化的ATP水解可通过在缬氨霉素和KCl存在的情况下添加ATP来诱导。这会导致线粒体内Pi增加,因此可以研究完整线粒体中潜在的Pi流出途径。将这种方法与内部和外部Pi的直接测量相结合,我们试图确定Pi流出是否通过对苍术苷敏感的转运体、通过Pi/H⁺和Pi/二羧酸载体的经典作用以及/或者通过其他机制发生。最初的实验重新审视了导致当前观点的证据,即Pi的一种流出途径是对苍术苷敏感的ATP/ADP、0.5Pi转运体。未发现支持这种流出途径的证据。相反,在先前研究(存在寡霉素)中观察到的低速率Pi流出对苍术苷的敏感性,是由于ATP通过众所周知的ATP/ADP转运系统进入,随后ATP水解以及随后的Pi流出所致。因此,在这些ATP水解未被完全抑制的条件下,Pi流出变得对苍术苷敏感,最可能是因为这种抑制剂阻断了ATP进入,而不是因为它直接抑制Pi流出。在缬氨霉素和K⁺(不存在寡霉素)诱导的ATP水解产生高水平基质Pi时,观察到大鼠肝脏线粒体中有大量Pi流出。这种流出的一部分可以被通常抑制Pi/H⁺和Pi/二羧酸载体的硫醇特异性试剂抑制。然而,即使在存在对氯汞苯甲酸、N - 乙基马来酰亚胺加正丁基丙二酸或汞撒利的情况下,仍有相当一部分流出继续存在。对汞撒利不敏感的Pi流出,对羧基苍术苷也不敏感,是一个可饱和的过程,因此表明有载体介导。在这种流出过程中,线粒体内膜对其他低分子量阴离子(即苹果酸、2 - 氧代戊二酸)仍保持相当的不渗透性。总之,此处给出的结果排除了对苍术苷敏感的ATP/ADP、0.5Pi转运系统作为大鼠肝脏线粒体中Pi流出机制的可能性。相反,Pi流出似乎通过经典的Pi/H⁺转运系统以及通过对汞撒利不敏感的可饱和过程发生。对抑制剂不敏感的Pi流出可能发生在一部分处于与正常催化Pi流入状态不同的Pi/H⁺载体分子上。或者,可能存在一个单独的Pi流出载体。